SNSE/LLY (SNSE/LLY)

Santiago Stock Exchange: SNSE/LLY · USD

$1,279

+38.80 (+3.1%)· Recorded snapshot

Market cap	1123.8T
Revenue (ttm)	73.4T
Net income (ttm)	24.6T
EPS (ttm)	$29,297
P/E (trailing)	42.9x
P/E (forward)	33.6x
Dividend	$6,122 (0.49%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 73.4T
Net income (ttm): 24.6T
EPS (ttm): $29,297
P/E (trailing): 42.9x
P/E (forward): 33.6x
Market cap: 1123.8T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E33.6

P25 n/aP50 n/aP75 n/a

Trailing P/E42.9

P25 n/aP50 n/aP75 n/a

ROE102.3

P25 n/aP50 n/aP75 n/a

ROIC42.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SNSE/LLY indicators

Market & fundamental data

Available fields

226

Groups with data

Currency

USD

Showing 226 of 226 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CLP
Country	United States
Country code	CL
Earnings date	2026-10-29
Employees	50,000
Employees change	3,000
Employees growth	6.38%
Enterprise value	$1168.1T
Exchange	Santiago Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-08-17
Fiscal year end	December
Founded	1876
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	US5324571083
Last refreshed	2026-10-28
Market cap	$1123.8T
Next earnings date	2026-10-29
Price	$1,279.10
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-27
Symbol	snse/LLY
Website	https://www.lilly.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	52.78x
Average P/E ratio (3Y)	71.41x
Average P/E ratio (5Y)	62.99x
Earnings yield	2.33%
EV/Earnings	47.4x
EV/EBIT	29.99x
EV/EBITDA	28.34x
EV/FCF	69.61x
EV/Sales	14.91x
FCF / EV yield	1.44%
FCF yield	1.49%
Forward P/E	33.58x
Graham number	149.84499
Graham upside	-88.29%
Lynch fair value	$701.25
Lynch upside	-45.18%
P/(FCF - SBC) ratio	69.44x
P/(OCF - SBC) ratio	44.4x
P/B ratio	35.95x
P/E ratio	42.94x
P/FCF ratio	66.96x
P/OCF ratio	43.37x
P/S ratio	15.29x
Price / tangible book value	176.02x
Price/EBITDA ratio	29.2x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	49.72%
EBITDA margin	52.35%
Effective tax rate	20.49%
FCF margin	21.39%
Gross margin	83.4%
Operating margin	49.72%
Pretax margin	42.17%
Profit margin	33.53%
Profit per employee	$492.2M
Profitable quarters	11
Profitable years	8
Revenue per employee	$1.5B
ROA	20.36%
ROA (5Y)	13.51%
ROCE	41.89%
ROE	102.29%
ROE (5Y)	74.21%
ROIC	42.24%
ROIC (5Y)	35.51%
SBC / revenue	0.81%
Tax / revenue	8.64%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	94.8%
EPS growth (Q)	26.23%
EPS growth (QoQ)	-3.87%
EPS growth 10Y	29.08%
EPS growth 3Y	60.68%
EPS growth 5Y	34.97%
EPS growth quarters	11
EPS growth years	2
FCF growth	272.37%
FCF growth (Q)	458.06%
FCF growth (QoQ)	157.96%
FCF growth 3Y	69.77%
FCF growth 5Y	26.73%
Gross profit growth	50.96%
Gross profit growth (Q)	50.31%
Gross profit growth 3Y	42.51%
Gross profit growth 5Y	26.7%
Net income growth	93.56%
Net income growth (Q)	25.33%
Net income growth (QoQ)	-4.07%
Net income growth 3Y	60.19%
Net income growth 5Y	34.49%
Net income growth quarters	11
Net income growth years	2
OCF growth	156.73%
OCF growth (Q)	246.29%
OCF growth (QoQ)	100.45%
OCF growth 10Y	23.94%
OCF growth 3Y	65.09%
OCF growth 5Y	31.67%
Operating income growth	78.34%
Operating income growth (Q)	77.42%
Operating income growth 3Y	68.37%
Operating income growth 5Y	38.93%
Revenue growth	49.58%
Revenue growth (Q)	47.67%
Revenue growth (QoQ)	16.04%
Revenue growth 10Y	14.48%
Revenue growth 3Y	39.23%
Revenue growth 5Y	24.41%
Revenue growth quarters	13
Revenue growth years	8

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-9.1T
Depreciation and amortization	$2.1T
EBIT	$36.5T
EBITDA	$38.4T
EPS	$29,296.95
Financing cash flow	$2.4T
Free cash flow	$16.8T
Free cash flow minus SBC	$16.2T
Gross profit	$61.2T
Income taxes	$6.3T
Investing cash flow	$-23.1T
Net borrowing	$15T
Net cash flow	$5.1T
Net income	$24.6T
Operating cash flow minus SBC	$25.3T
Operating income	$36.5T
Revenue	$73.4T
Stock-based compensation	$597.9B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	6.55
Book value per share	$35,011.47
Debt / EBITDA	1.31
Debt / equity	1.62
Debt / FCF	3.02
Goodwill	$8.7T
Interest coverage	215.26
Long-term assets	$67.5T
Long-term liabilities	$52.9T
Net cash (debt)	$-41.6T
Net cash / market cap	-3.71%
Net debt / EBITDA	1.08
Net debt / equity	1.33
Net debt / FCF	2.48
Piotroski F-Score	7
Property, plant and equipment	$28.8T
Shareholders' equity	$31.2T
Tangible book value	$6.4T
Tangible book value per share	$7,151.31
Total assets	$131.1T
Total cash	$8.2T
Total debt	$50.6T
Total liabilities	$99.9T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.66
Current assets	$63.6T
Current liabilities	$47T
Current ratio	1.35
Inventory turnover	0.95
Net working capital	$13.8T
Quick ratio	0.68
Working capital	$15.6T
Working capital turnover	5,286.95

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.62%
Dividend growth	15.34%
Dividend growth years	2
Dividend payment date	2026-09-10
Dividend payment years	4
Dividend payout frequency	Quarterly
Dividend per share	$6,121.89
Dividend yield	0.49%
Ex-dividend date	2026-08-14
Last dividend	$1.73
Payout ratio	21.66%
Shareholder yield	1.11%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$1,121.72
1D price change	3.13%
1M price change	9.8%
1M total return	9.8%
1W price change	9.65%
1W total return	9.65%
1Y price change	75.16%
1Y return CAGR	76.33%
1Y total return	76.26%
20-day SMA	$1,189.31
200-day SMA	$1,110.63
3M price change	11.53%
3M total return	11.68%
50-day SMA	$1,190.27
50-day SMA vs 200-day SMA	50over200
52-week high	$1,279.10
52-week high date	2026-10-27
52-week low	$730.23
52-week low date	2025-11-03
6M price change	16.34%
6M total return	16.71%
All-time high	$1,279.10
All-time high date	2026-10-27
All-time low	$632.01
All-time low date	2025-08-08
Average true range (ATR)	$10.57
Average volume	0
Change from 52-week high	0%
Change from 52-week low	75.16%
Change from all-time high	0%
Change from all-time low	102.39%
Monthly RSI	68.72
Previous close	$1,240.30
Price vs 150-day SMA	14.03%
Price vs 20-day SMA	7.55%
Price vs 200-day SMA	15.17%
Price vs 50-day SMA	7.46%
RSI	80.44
Sharpe ratio	1.64
Sortino ratio	3.6
Weekly RSI	63.62
YTD price change	23.74%
YTD total return	24.33%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	888.9M
Shares change (QoQ)	-0.25%
Shares change (YoY)	-0.62%
Shares held by insiders	0.17%
Shares held by institutions	89.36%
Short ratio	2.8 days

Deeper analysis on SNSE/LLY

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SNSE/LLY report

Is a complete SNSE/LLY research report available?

No complete published report is available for snse/LLY (SNSE/LLY) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

SNSE/LLY (SNSE/LLY)

Price

Financial snapshot

Fair-value bridge

Latest news · SNSE/LLY

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SNSE/LLY indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SNSE/LLY

Frequently asked questions